0001447028-22-000011.txt : 20220120 0001447028-22-000011.hdr.sgml : 20220120 20220120175510 ACCESSION NUMBER: 0001447028-22-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220120 FILED AS OF DATE: 20220120 DATE AS OF CHANGE: 20220120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS DAVID C CENTRAL INDEX KEY: 0001237401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 22543391 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 701 VETERANS CIRCLE CITY: WARMINSTER STATE: PA ZIP: 18974 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 wf-form4_164271929611191.xml FORM 4 X0306 4 2022-01-20 0 0001447028 Arbutus Biopharma Corp ABUS 0001237401 HASTINGS DAVID C C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE WARMINSTER PA 18974 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 2.81 2022-01-20 4 A 0 285000 2.81 A 2032-01-20 Common Shares 285000.0 285000 D These stock options will vest and become exercisable 1/48th each month over the four year period. David C Hastings 2022-01-20